Screener / SEC EDGAR /CIK 0001617640 /10-K filed Feb 11, 2026, compared with Feb 11, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Industrials · Business Services

Zillow Group, Inc. ZG

Compare with peers Embed
Planned sales, announced before they happen

8 trading plans running, 60 Form 144 notices for $15.8M

10-Q, 10-K and Form 144
Plans running now 8 Dan Spaulding, Claire Cormier Thielke, Amy Bohutinsky, Erik Blachford, Jeremy Wacksman, Richard N. Barton, Jeremy Hofmann, Bradley D. Owens
Plans adopted 23 reported since May 3, 2023 Form 144 notices 60 $15.8M the sellers expected to sell

What ZG's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Plans adopted or ended

Trading plans · XBRL, 10-Q and 10-K

From Mar 13, 2025 to Aug 18, 2028. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.

InsiderWhatDateReported in
Dan Spaulding
Chief People Officer
Adopted 10b5-1 plan Aug 28, 2026 10-Q Nov 4, 2026
What the company wrote
On August 28, 2026, Dan Spaulding, Chief People Officer of the Company, entered into a 10b5-1 sales plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. This 10b5-1 sales plan provides for (1) the sale of up to 258,287 shares of Class C capital stock related to the exercise of option awards granted to Mr. Spaulding and (2) the sale of an indeterminate number of shares of Class C capital stock related to the vesting of restricted stock units granted to Mr. Spaulding. The number of shares of Class C capital stock that will be sold under this 10b5-1 sales plan related to vesting of restricted stock units is not yet determinable because (i) certain future awards granted during the life of the plan that follow the same vesting schedule as existing awards under the plan may be covered by the terms of the plan and (ii) for each vested restricted stock unit that is covered by the terms of the plan, an unknown number of shares will be sold to satisfy tax withholding prior to any sale occurring under the terms of the plan. This 10b5-1 sales plan will become effective on November 27, 2026 and will terminate on August 18, 2028, subject to earlier termination as provided in the plan.
Claire Cormier Thielke
member of the Board
Adopted 10b5-1 plan May 12, 2026 10-Q Aug 5, 2026
What the company wrote
On May 12, 2026, Claire Cormier Thielke, member of the Board, entered into a 10b5-1 sales plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. This 10b5-1 sales plan provides for the sale of an indeterminate number of shares of Class C capital stock related to the vesting of restricted stock units granted to Ms. Thielke. The number of shares of Class C capital stock that will be sold under this 10b5-1 sales plan is not yet determinable because certain future awards granted during the life of the plan that follow the same vesting schedule as existing awards under the plan may be covered by the terms of the plan. This 10b5-1 sales plan will become effective on August 11, 2026 and will terminate on March 3, 2027, subject to earlier termination as provided in the plan.
Amy Bohutinsky
member of the Board
Adopted 10b5-1 plan Mar 6, 2026 10-Q May 6, 2026
What the company wrote
On March 6, 2026, Amy Bohutinsky, member of the Board, entered into a 10b5-1 sales plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. This 10b5-1 sales plan provides for the sale of up to 105,884 shares of Class C capital stock related to the exercise of option awards granted to Ms. Bohutinsky. This 10b5-1 sales plan will become effective on June 8, 2026 and will terminate on March 7, 2027, subject to earlier termination as provided in the plan.
Erik Blachford
member of the Board
Adopted 10b5-1 plan Mar 4, 2026 10-Q May 6, 2026
What the company wrote
On March 4, 2026, Erik Blachford, member of the Board, entered into a 10b5-1 sales plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. This 10b5-1 sales plan provides for the sale of an indeterminate number of shares of Class C capital stock related to the vesting of restricted stock units granted to Mr. Blachford. The number of shares of Class C capital stock that will be sold under this 10b5-1 sales plan is not yet determinable because certain future awards granted during the life of the plan that follow the same vesting schedule as existing awards under the plan may be covered by the terms of the plan. This 10b5-1 sales plan will become effective on June 8, 2026 and will terminate on March 4, 2027, subject to earlier termination as provided in the plan.
Jeremy Wacksman
Chief Executive Officer
Adopted 10b5-1 plan Feb 20, 2026 10-Q May 6, 2026
What the company wrote
On February 20, 2026, Jeremy Wacksman, Chief Executive Officer of the Company and member of the Board, entered into a 10b5-1 sales plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. This 10b5-1 sales plan provides for the sale of an indeterminate number of shares of Class C capital stock related to the vesting of restricted stock units granted to Mr. Wacksman. The number of shares of Class C capital stock that will be sold under this 10b5-1 sales plan is not yet determinable because (i) certain future awards granted during the life of the plan that follow the same vesting schedule as existing awards under the plan may be covered by the terms of the plan and (ii) for each vested restricted stock unit award that is covered by the terms of the plan, an unknown number of shares will be sold to satisfy tax withholding prior to any sale occurring under the terms of the plan. This 10b5-1 sales plan will become effective on May 22, 2026 and will terminate on February 20, 2027, subject to earlier termination as provided in the plan.
Lloyd D. Frink
co-founder, President of the Company, and Co-Executive Chairman of the Board
Adopted 10b5-1 plan Feb 11, 2026 10-Q May 6, 2026
What the company wrote
On February 11, 2026, Lloyd D. Frink, co-founder, President of the Company, and Co-Executive Chairman of the Board, terminated a previously disclosed 10b5-1 sales plan that was intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and was entered into on December 11, 2024. The 10b5-1 sales plan provided for an aggregate sale of (i) up to 200,000 shares of Class C capital stock plus (ii) up to an additional 200,000 shares of Class C capital stock related to the exercise of option awards granted to Mr. Frink.
Richard N. Barton
co-founder and Co-Executive Chairman of the Board
Adopted 10b5-1 plan Feb 11, 2026 10-Q May 6, 2026
What the company wrote
On February 11, 2026, Richard N. Barton, co-founder and Co-Executive Chairman of the Board, terminated a previously disclosed 10b5-1 sales plan that was intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and was entered into on December 11, 2024. The 10b5-1 sales plan provided for the sale of up to 300,000 shares of Class C capital stock related to the exercise of option awards granted to Mr. Barton. On February 27, 2026, Mr. Barton entered into a 10b5-1 sales plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. This 10b5-1 sales plan was amended on March 5, 2026 and provides for an aggregate sale of (i) up to 300,000 shares of Class C capital stock plus (ii) up to an additional 163,980 shares of Class C capital stock related to the exercise of option awards granted to Mr. Barton. This 10b5-1 sales plan will become effective on June 8, 2026 and will terminate on June 7, 2027, subject to earlier termination as provided in the plan.
Jeremy Hofmann
Chief Financial Officer
Adopted 10b5-1 plan Nov 19, 2025 10-K Feb 11, 2026
What the company wrote
On November 19, 2025, Jeremy Hofmann, Chief Financial Officer of the Company, entered into a 10b5-1 sales plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. This 10b5-1 sales plan provides for (1) the sale of up to 100,000 shares of Class C capital stock related to the exercise of option awards granted to Mr. Hofmann and (2) the sale of an indeterminate number of shares of Class C capital stock related to the vesting of restricted stock units granted to Mr. Hofmann. The number of shares of Class C capital stock that will be sold under this 10b5-1 sales plan related to vesting of restricted stock unit awards is not yet determinable because (i) certain future awards granted during the life of the plan that follow the same vesting schedule as existing awards under the plan may be covered by the terms of the plan and (ii) for each vested restricted stock unit award that is covered by the terms of the plan, an unknown number of shares will be sold to satisfy tax withholding prior to any sale occurring under the terms of the plan. This 10b5-1 sales plan will become effective on February 17, 2026 and will terminate on February 16, 2027, subject to earlier termination as provided in the plan.
Bradley D. Owens
General Counsel and Corporate Secretary
Adopted 10b5-1 plan Aug 19, 2025 10-Q Oct 30, 2025
What the company wrote
On August 19, 2025, Bradley D. Owens, General Counsel and Corporate Secretary of the Company, entered into a 10b5-1 sales plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. This 10b5-1 sales plan provides for (1) the sale of up to 470,670 shares of Class C capital stock related to the exercise of option awards granted to Mr. Owens and (2) the sale of an indeterminate number of shares of Class C capital stock related to the vesting of restricted stock units granted to Mr. Owens. The number of shares of Class C capital stock that will be sold under this 10b5-1 sales plan related to vesting of restricted stock unit awards is not yet determinable because (i) certain future awards granted during the life of the plan that follow the same vesting schedule as existing awards under the plan may be covered by the terms of the plan and (ii) for each vested restricted stock unit award that is covered by the terms of the plan, an unknown number of shares will be sold to satisfy tax withholding prior to any sale occurring under the terms of the plan. This 10b5-1 sales plan will become effective on November 19, 2025 and will terminate on August 19, 2027, subject to earlier termination as provided in the plan.
Claire Cormier Thielke
member of the Board
Adopted 10b5-1 plan Mar 13, 2025 10-Q May 7, 2025
What the company wrote
On March 13, 2025, Claire Cormier Thielke, member of the Board, entered into a 10b5-1 sales plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. This 10b5-1 sales plan provides for the sale of an indeterminate number of shares of Class C capital stock related to the vesting of restricted stock units granted to Ms. Thielke. The number of shares of Class C capital stock that will be sold under this 10b5-1 sales plan is not yet determinable because certain future awards granted during the life of the plan that follow the same vesting schedule as existing awards under the plan may be covered by the terms of the plan. This 10b5-1 sales plan will become effective on June 11, 2025, and will terminate on March 4, 2026, subject to earlier termination as provided in the plan.
Erik Blachford
member of the Board
Adopted 10b5-1 plan Mar 7, 2025 10-Q May 7, 2025
What the company wrote
On March 7, 2025, Erik Blachford, member of the Board, entered into a 10b5-1 sales plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. This 10b5-1 sales plan provides for the sale of an indeterminate number of shares of Class C capital stock related to the vesting of restricted stock units granted to Mr. Blachford. The number of shares of Class C capital stock that will be sold under this 10b5-1 sales plan is not yet determinable because certain future awards granted during the life of the plan that follow the same vesting schedule as existing awards under the plan may be covered by the terms of the plan. This 10b5-1 sales plan will become effective on June 9, 2025 and will terminate on March 4, 2026, subject to earlier termination as provided in the plan.
Jun Choo
Chief Operating Officer of the Company
Ended 10b5-1 plan Feb 28, 2025 10-Q May 7, 2025
What the company wrote
On February 28, 2025, Jun Choo, Chief Operating Officer of the Company, terminated a previously disclosed 10b5-1 sales plan that was intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and was entered into on December 5, 2024. The 10b5-1 sales plan provided for the sale of up to 50,085 shares of Class C capital stock related to the exercise of option awards granted to Mr. Choo. No shares were sold under the plan prior to its termination.
Jeremy Wacksman
Chief Executive Officer of the Company and member of the Board
Adopted 10b5-1 plan Feb 13, 2025 10-Q May 7, 2025
What the company wrote
On February 13, 2025, Jeremy Wacksman, Chief Executive Officer of the Company and member of the Board, entered into a 10b5-1 sales plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. This 10b5-1 sales plan provides for (1) the sale of up to 147,609 shares of Class C capital stock related to the exercise of option awards granted to Mr. Wacksman and (2) the sale of an indeterminate number of shares of Class C capital stock related to the vesting of restricted stock units granted to Mr. Wacksman. The number of shares of Class C capital stock that will be sold under this 10b5-1 sales plan related to vesting of restricted stock unit awards is not yet determinable because (i) certain future awards granted during the life of the plan that follow the same vesting schedule as existing awards under the plan may be covered by the terms of the plan and (ii) for each vested restricted stock unit award that is covered by the terms of the plan, an unknown number of shares will be sold to satisfy tax withholding prior to any sale occurring under the terms of the plan. This 10b5-1 sales plan will become effective on May 16, 2025 and will terminate on February 27, 2026, subject to earlier termination as provided in the plan.
Lloyd D. Frink
co-founder, President of the Company, and Co-Executive Chairman of the Board
Adopted 10b5-1 plan Dec 11, 2024 10-K Feb 11, 2025
What the company wrote
On December 11, 2024, Lloyd D. Frink, co-founder, President of the Company, and Co-Executive Chairman of the Board, entered into a 10b5-1 sales plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. This 10b5-1 sales plan provides for an aggregate sale of (i) up to 200,000 shares of Class C capital stock plus (ii) up to an additional 200,000 shares of Class C capital stock related to the exercise of option awards granted to Mr. Frink. This 10b5-1 sales plan will become effective on April 14, 2025 and will terminate on March 12, 2026, subject to earlier termination as provided in the plan.
Richard N. Barton
co-founder and Co-Executive Chairman of the Board
Adopted 10b5-1 plan Dec 11, 2024 10-K Feb 11, 2025
What the company wrote
On December 11, 2024, Richard N. Barton, co-founder and Co-Executive Chairman of the Board, entered into a 10b5-1 sales plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. This 10b5-1 sales plan provides for the sale of up to 300,000 shares of Class C capital stock related to the exercise of option awards granted to Mr. Barton. This 10b5-1 sales plan will become effective on April 1, 2025 and will terminate on March 25, 2026, subject to earlier termination as provided in the plan.
Jun Choo
Chief Operating Officer
Adopted 10b5-1 plan Dec 5, 2024 10-K Feb 11, 2025
What the company wrote
On December 5, 2024, Jun Choo, Chief Operating Officer of the Company, entered into a 10b5-1 sales plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. This 10b5-1 sales plan provides for the sale of up to 50,085 shares of Class C capital stock related to the exercise of option awards granted to Mr. Choo. This 10b5-1 sales plan will become effective on March 10, 2025 and will terminate on March 13, 2026, subject to earlier termination as provided in the plan.
Jeremy Hofmann
Chief Financial Officer
Adopted 10b5-1 plan Sep 4, 2024 10-Q Nov 6, 2024
What the company wrote
On September 4, 2024, Jeremy Hofmann, Chief Financial Officer of the Company, entered into a 10b5-1 sales plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. This 10b5-1 sales plan provides for (1) the sale of up to 100,000 shares of Class C capital stock related to the exercise of option awards granted to Mr. Hofmann and (2) the sale of an indeterminate number of shares of Class C capital stock related to the vesting of restricted stock units granted to Mr. Hofmann. The number of shares of Class C capital stock that will be sold under this 10b5-1 sales plan related to vesting of restricted stock unit awards is not yet determinable because (i) certain future awards granted during the life of the plan that follow the same vesting schedule as existing awards under the plan may be covered by the terms of the plan and (ii) for each vested restricted stock unit award that is covered by the terms of the plan, an unknown number of shares will be sold to satisfy tax withholding prior to any sale occurring under the terms of the plan. This 10b5-1 sales plan will become effective on December 4, 2024 and will terminate on December 31, 2025, subject to earlier termination as provided in the plan.
Dan Spaulding
Chief People Officer
Adopted 10b5-1 plan Aug 30, 2024 10-Q Nov 6, 2024
What the company wrote
On August 30, 2024, Dan Spaulding, Chief People Officer of the Company, entered into a 10b5-1 sales plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. This 10b5-1 sales plan provides for (1) the sale of up to 244,997 shares of Class C capital stock related to the exercise of option awards granted to Mr. Spaulding and (2) the sale of an indeterminate number of shares of Class C capital stock related to the vesting of restricted stock units granted to Mr. Spaulding. The number of shares of Class C capital stock that will be sold under this 10b5-1 sales plan related to vesting of restricted stock unit awards is not yet determinable because (i) certain future awards granted during the life of the plan that follow the same vesting schedule as existing awards under the plan may be covered by the terms of the plan and (ii) for each vested restricted stock unit award that is covered by the terms of the plan, an unknown number of shares will be sold to satisfy tax withholding prior to any sale occurring under the terms of the plan. This 10b5-1 sales plan will become effective on November 29, 2024 and will terminate on May 21, 2026, subject to earlier termination as provided in the plan.
Claire Cormier Thielke
member of the Board
Adopted 10b5-1 plan Jun 10, 2024 10-Q Aug 7, 2024
What the company wrote
On June 10, 2024, Claire Cormier Thielke, member of the Board, entered into a 10b5-1 sales plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. This 10b5-1 sales plan provides for an aggregate sale of (i) 1,413 shares of Class C capital stock plus (ii) an indeterminate number of shares of Class C capital stock related to the future vesting of certain restricted stock units between September 1, 2024 and March 1, 2025. This 10b5-1 sales plan will become effective on September 16, 2024 and will terminate on March 4, 2025, subject to earlier termination as provided in this 10b5-1 sales plan.
Erik Blachford
member of the Board
Adopted 10b5-1 plan Mar 12, 2024 10-Q May 1, 2024
What the company wrote
On March 12, 2024, Erik Blachford, member of the Board of Zillow Group, Inc., entered into a 10b5-1 sales plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. This 10b5-1 sales plan provides for the sale of an indeterminate number of shares of Class C capital stock related to future vesting of restricted stock units. This 10b5-1 sales plan will become effective on June 11, 2024 and will terminate on March 3, 2025, subject to earlier termination as provided in the 10b5-1 sales plan.
Jeremy Wacksman
Chief Operating Officer
Adopted 10b5-1 plan Feb 16, 2024 10-Q Aug 7, 2024
What the company wrote
In addition, in the Company’s Quarterly Report on Form 10-Q filed with the SEC on May 1, 2024, the Company inadvertently omitted disclosure regarding the entry into a 10b5-1 sales plan by Jeremy Wacksman, Chief Operating Officer, on February 16, 2024. This 10b5-1 sales plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act and provides for the sale of an indeterminate number of shares of Class C capital stock related to the vesting of restricted stock units. This 10b5-1 sales plan became effective on May 17, 2024 and will terminate on February 18, 2025, subject to earlier termination upon the sale of all shares of Class C capital stock subject to this 10b5-1 sales plan or as otherwise provided in this 10b5-1 sales plan.
Jeremy Hofmann
Chief Financial Officer
Adopted 10b5-1 plan Dec 11, 2023 10-K Feb 15, 2024
What the company wrote
On December 11, 2023, Jeremy Hofmann, Chief Financial Officer of Zillow Group, Inc., entered into a 10b5-1 sales plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. This 10b5-1 sales plan provides for the sale of an indeterminate number of shares of Class C capital stock related to future vesting of restricted stock units. This 10b5-1 sales plan will become effective on March 15, 2024 and will terminate on November 29, 2024, subject to earlier termination as provided in the 10b5-1 sales plan.
Amy Bohutinsky
Director
Adopted 10b5-1 plan Dec 4, 2023 10-K Feb 15, 2024
What the company wrote
On December 4, 2023, Amy Bohutinsky, Director of Zillow Group, Inc., entered into a 10b5-1 sales plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. This 10b5-1 sales plan provides for the exercise of option awards and sale of up to 125,000 shares of Class A common stock and 270,625 shares of Class C capital stock. This 10b5-1 sales plan will become effective on March 4, 2024 and will terminate on January 7, 2025, subject to earlier termination upon the exercise of option awards and sale of all shares of Class A common stock or Class C capital stock subject to the 10b5-1 sales plan or as otherwise provided in this 10b5-1 sales plan.
Brad Owens
General Counsel
Adopted 10b5-1 plan Aug 21, 2023 10-Q Nov 1, 2023
What the company wrote
On August 21, 2023, Brad Owens, General Counsel, entered into a 10b5-1 sales plan (the “10b5-1 Sales Plan”) intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The 10b5-1 Sales Plan provides for the exercise of option awards and sale of up to 127,625 shares of Class C capital stock and the sale of an indeterminate number of shares of Class C capital stock related to future vesting of restricted stock units. The 10b5-1 Sales Plan will become effective on November 20, 2023 and will terminate on August 18, 2025, subject to earlier termination upon the exercise of option awards and sale of all shares of Class C capital stock subject to the 10b5-1 Sales Plan or as otherwise provided in the 10b5-1 Sales Plan.
Show the other 16 plans

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 3, 2023.

Notices of planned sales

Form 144 · Form 144 XML, SEC

What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).

FiledSellerSharesValue
Nov 12, 2026 Wacksman Jeremy
Officer, Director
5,989 $176K
Nov 12, 2026 Tremblay Rikki
Officer
1,065 $31K
Nov 12, 2026 Spaulding Dan
Officer
2,035 $60K
Nov 12, 2026 Samuelson Errol G
Officer
3,075 $90K
Nov 12, 2026 Rock Jennifer
Former Affiliate
1,655 $48K
Nov 12, 2026 Hofmann Jeremy
Officer
3,631 $106K
Nov 12, 2026 Beitel David A.
Officer
1,860 $55K
Sep 3, 2026 Cormier Thielke Claire
Director
1,187 $42K
Sep 3, 2026 BLACHFORD ERIK C
Director
792 $28K
Aug 17, 2026 Wacksman Jeremy
Officer, Director
9,339 $319K
Aug 17, 2026 Hofmann Jeremy
Officer
5,661 $193K
Aug 14, 2026 Owens Bradley D.
Former Affiliate
3,463 $125K
Aug 14, 2026 Spaulding Dan
Officer
3,169 $112K
Aug 13, 2026 Wacksman Jeremy
Officer, Director
5,786 $198K
Aug 13, 2026 Spaulding Dan
Officer
1,966 $67K
Aug 13, 2026 Samuelson Errol G
Officer
3,154 $108K
Aug 13, 2026 Rock Jennifer
Officer
990 $34K
Aug 13, 2026 Owens Bradley D.
Former Affiliate
2,148 $74K
Aug 13, 2026 Hofmann Jeremy
Officer
3,510 $120K
Aug 13, 2026 Choo Jun
Former Affiliate
1,617 $55K
Aug 13, 2026 Beitel David A.
Officer
1,798 $62K
Aug 11, 2026 Cormier Thielke Claire
Director
1,187 $39K
Jun 8, 2026 BLACHFORD ERIK C
Director
791 $28K
May 22, 2026 Wacksman Jeremy
Officer, Director
9,072 $331K
May 18, 2026 Spaulding Dan
Officer
3,078 $115K
May 18, 2026 Hofmann Jeremy
Officer
5,501 $206K
May 15, 2026 Owens Bradley D.
Officer
3,364 $125K
May 14, 2026 Wacksman Jeremy
Officer, Director
6,051 $229K
May 14, 2026 Spaulding Dan
Officer
2,056 $78K
May 14, 2026 Samuelson Errol G
Officer
2,939 $112K
May 14, 2026 Rock Jennifer
Officer
1,034 $39K
May 14, 2026 Owens Bradley D.
Officer
2,246 $85K
May 14, 2026 Hofmann Jeremy
Officer
3,671 $139K
May 14, 2026 Choo Jun
Officer
1,228 $47K
May 14, 2026 Beitel David A.
Officer
1,879 $71K
Mar 26, 2026 Samuelson Errol G
Officer
4,734 $209K
Mar 24, 2026 Owens Bradley D.
Officer
8,800 $384K
Mar 3, 2026 Cormier Thielke Claire
Director
242 $10K
Mar 3, 2026 BLACHFORD ERIK C
Director
966 $41K
Feb 27, 2026 MAFFEI GREGORY B
Director
8,050 $363K
Feb 20, 2026 Frink Lloyd D
Officer, Director, Co -Exec. Chairman & President
39,663 $1.8M
Feb 18, 2026 Hofmann Jeremy
Officer
7,786 $340K
Feb 17, 2026 Wacksman Jeremy
Officer, Director
13,661 $605K
Feb 17, 2026 Spaulding Dan
Officer
5,361 $236K
Feb 13, 2026 Owens Bradley D.
Officer
2,602 $116K
Feb 12, 2026 Wacksman Jeremy
Officer, Director
4,729 $209K
Feb 12, 2026 Spaulding Dan
Officer
3,901 $172K
Feb 12, 2026 Samuelson Errol G
Officer
7,015 $310K
Feb 12, 2026 Rock Jennifer
Officer
2,164 $96K
Feb 12, 2026 Owens Bradley D.
Officer
2,017 $89K
Feb 12, 2026 Hofmann Jeremy
Officer
5,538 $245K
Feb 12, 2026 Choo Jun
Officer
2,061 $91K
Feb 12, 2026 Beitel David A.
Officer
3,966 $175K
Feb 9, 2026 Frink Lloyd D
Officer, Director, Co -Exec. Chairman & President
84,168 $4.6M
Dec 3, 2025 Cormier Thielke Claire
Director
241 $17K
Dec 3, 2025 BLACHFORD ERIK C
Director
965 $70K
Nov 19, 2025 Owens Bradley D.
Officer
2,722 $183K
Nov 14, 2025 Wacksman Jeremy
Officer, Director
10,855 $760K
Nov 14, 2025 Spaulding Dan
Officer
5,455 $379K
Nov 14, 2025 Hofmann Jeremy
Officer
7,865 $547K
Show the other 52 notices

From the Form 144 XML filed with the SEC, since Nov 14, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Sources

Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.

Also

Insider trades: the Form 4s for the sales these plans led to.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/ZG/export.csv") into a cell.

Next:Owners
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.